Bank of Montreal
VBIV

Bank of Montreal’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Bank of Montreal’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,165
Closed -$11.7K – 4375
2023
Q1 		$11.7K Buy
1,165
+589
+102% +$8.34K ﹤0.01% 3596
2022
Q4 		$9.16K Sell
576
-167
-22% -$2.95K ﹤0.01% 3783
2022
Q3 		$18 Sell
743
-5
-0.7% -$135 ﹤0.01% 3821
2022
Q2 		$20 Sell
748
-54
-7% -$1.84K ﹤0.01% 3771
2022
Q1 		$40K Sell
802
-10
-1% -$494 ﹤0.01% 3822
2021
Q4 		$59K Buy
812
+67
+9% +$5.64K ﹤0.01% 3213
2021
Q3 		$74K Sell
745
-700
-48% -$66.5K ﹤0.01% 3500
2021
Q2 		$146K Sell
1,445
-1,341
-48% -$131K ﹤0.01% 3274
2021
Q1 		$240K Buy
2,786
+366
+15% +$37.1K ﹤0.01% 3036
2020
Q4 		$221K Buy
2,420
+667
+38% +$56.9K ﹤0.01% 3175
2020
Q3 		$149K Sell
1,753
-31
-2% -$3.61K ﹤0.01% 2868
2020
Q2 		$217K Buy
1,784
+397
+29% +$21.9K ﹤0.01% 2689
2020
Q1 		$39K Sell
1,387
-190
-12% -$7.39K ﹤0.01% 2995
2019
Q4 		$66K Buy
1,577
+76
+5% +$1.66K ﹤0.01% 3708
2019
Q3 		$22K Buy
1,501
+248
+20% +$5.19K ﹤0.01% 4048
2019
Q2 		$44K Buy
1,253
+523
+72% +$28.4K ﹤0.01% 3762
2019
Q1 		$41K Buy
730
+130
+22% +$7.03K ﹤0.01% 3418
2018
Q4 		$29K Buy
600
+433
+259% +$23.7K ﹤0.01% 3504
2018
Q3 		$12K Buy
+167
New +$11K ﹤0.01% 3882
2017
Q4 		– Sell
-1,813
Closed -$209K – 4364
2017
Q3 		$209K Sell
1,813
-300
-14% -$36K ﹤0.01% 2653
2017
Q2 		$277K Buy
2,113
+166
+9% +$22.4K ﹤0.01% 2497
2017
Q1 		$321K Buy
1,947
+778
+67% +$105K ﹤0.01% 2266
2016
Q4 		$101K Sell
1,169
-425
-27% -$40.6K ﹤0.01% 2838
2016
Q3 		$164K Buy
+1,594
New +$179K ﹤0.01% 2534

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's VBIV Position: Q2 2023 in Review

Bank of Montreal sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2023, closing a stake of 1,165 shares — an estimated $11.7K sold.

Bank of Montreal first reported a position in VBIV in Q3 2016 and held it in 24 quarters. The position peaked at $321K in Q1 2017. 46 funds tracked by Wall St. Rank hold VBIV as of Q2 2023.

  • Bank of Montreal reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2023 after selling out during the quarter.
  • Bank of Montreal sold 1,165 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2023, an estimated $11.7K.
  • Bank of Montreal first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2016 and held it in 24 quarters.
  • Bank of Montreal's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $321K in Q1 2017.
  • 46 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.